Evan Kovac Research

Prasad SM, Kovac E. Editorial Comment. J Urol. 2023 Jul;210(1):105-106. doi: 10.1097/JU.00000000
00003461.01. Epub 2023 Apr 27. PubMed PMID: 37102721.

Fastenau J, Jain K, Popovic A, Kovac E. Review of Active Surveillance in Underrepresented and High-Risk Populations: Feasibility and Safety. Curr Urol Rep. 2023 Jul;24(7):307-315. doi: 10.1007/s11934-023-01158-5. Epub 2023 Mar 30. Review. PubMed PMID: 36995563.

Labagnara K, Zhu D, Loloi J, Shreck E, Abeshouse M, Watts KL, Sankin A, Aboumohamed AA, Kovac E. Low risk is low risk, regardless of race or ethnicity: Outcomes of prostate cancer active surveillance and factors associated with reclassification in a racially diverse cohort. Urol Oncol. 2023 Apr;41(4):204.e7-204.e15. doi: 10.1016/j.urolonc.2023.
01.007. Epub 2023 Feb 3. PubMed PMID: 36740489.

Feiertag N, Barry E, Abramson M, Park JY, Kovac E, Aboumohamed A, Watts K, Sankin A. Urine Cytology Rarely Escalates Clinical Management in the Surveillance of Non-muscle-Invasive Bladder Cancer. Clin Genitourin Cancer. 2023 Apr;21(2):258-264. doi: 10.1016/j.clgc.2022.12.00
4. Epub 2022 Dec 23. PubMed PMID: 36621462.

Kovac E. Editorial Comment. J Urol. 2023 Jan;209(1):206-207. doi: 10.1097/JU.0000000000
002956.02. Epub 2022 Oct 4. PubMed PMID: 36194554.

Zhu D, Loloi J, Labagnara K, Schwartz D, Agalliu I, Fram EB, Sankin A, Aboumohamed A, Kovac E. Clinical Risk Factors Associated With Small Renal Mass Malignant Histology in a Multi-Ethnic Population Undergoing Partial Nephrectomy. Clin Genitourin Cancer. 2022 Dec;20(6):e465-e472. doi: 10.1016/j.clgc.2022.06.
004. Epub 2022 Jun 8. PubMed PMID: 35768315.

Tilburt JC, Zahrieh D, Pacyna JE, Petereit DG, Kaur JS, Rapkin BD, Grubb RL 3rd, Chang GJ, Morris MJ, Kovac EZ, Babaian KN, Sloan JA, Basch EM, Peil ES, Dueck AC, Novotny PJ, Paskett ED, Buckner JC, Joyce DD, Montori VM, Frosch DL, Volk RJ, Kim SP. Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD). Cancer. 2022 Mar 15;128(6):1242-1251. doi: 10.1002/cncr.34062.
Epub 2021 Dec 10. PubMed PMID: 34890060; PubMed Central PMCID: PMC8882149.

Zhu D, Shyr W, Toker M, Fram E, Cheng J, Kovac EZ, Agalliu I, Aboumohamed A, Watts KL. The impact of surgical downgrading on prostate cancer recurrence: systematic review and analysis of a multiethnic population. World J Urol. 2022 Mar;40(3):709-718. doi: 10.1007/s00345-021-03892-2. Epub 2021 Nov 30. PubMed PMID: 34850269.

Kim JI, Zhu D, Barry E, Kovac E, Aboumohamed A, Agalliu I, Sankin A. Intravesical Bacillus Calmette-Guérin Treatment Is Inversely Associated With the Risk of Developing Alzheimer Disease or Other Dementia Among Patients With Non-muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2021 Dec;19(6):e409-e416. doi: 10.1016/j.clgc.2021.05.00
1. Epub 2021 May 17. PubMed PMID: 34116955.

Loloi J, Kuan K, Cheng J, Kovac E, Aboumohamed A. Ureteral metastasis in colorectal cancer: A case report and review of literature. Urol Case Rep. 2021 Nov;39:101851. doi: 10.1016/j.eucr.2021.101
851. eCollection 2021 Nov. PubMed PMID: 34567977; PubMed Central PMCID: PMC8449067.

Bernstein AP, Davuluri M, DeMasi M, Sankin A, Watts K, Aboumohamed A, Stern JM, Rocca J, Greenstein S, Graham JA, Ajaimy M, Liriano-Ward L, Sarungbam J, Kovac E. Native kidney small renal masses in patients with kidney transplants: Does chronic immunosuppression affect tumor biology?. Can Urol Assoc J. 2021 Oct;15(10):339-344. doi: 10.5489/cuaj.6996. Pub
Med PMID: 33750519; PubMed Central PMCID: PMC8525532.

Hines L, Zhu D, DeMasi M, Babar M, Chernyak V, Kovac EZ, Aboumohamed A, Sankin A, Agalliu I, Watts KL. A Comparison of Image-Guided Targeted Prostate Biopsy Outcomes by PI-RADS® Score and Ethnicity in a Diverse, Multiethnic Population. J Urol. 2021 Sep;206(3):586-594. doi: 10.1097/JU.000000000
0001810. Epub 2021 Apr 21. PubMed PMID: 33881932.

Barry E, Agalliu I, Maiman R, Shreck E, Kovac E, Aboumohamed A, Sankin A. OUTCOMES OF INTRAVESICAL BACILLUS CALMETTE-GUERIN IN A MULTIRACIAL COHORT WITH NON-MUSCLE-INVASIVE BLADDER CANCER. Urol Pract. 2021 Jan;8(1):100-105. doi: 10.1097/upj.0000000000
000154. Epub 2021 Jan 1. PubMed PMID: 34017909; PubMed Central PMCID: PMC8130652.

Watts KL, Frechette L, Muller B, Ilinksy D, Kovac E, Sankin A, Aboumohamed A. Systematic review and meta-analysis comparing cognitive vs. image-guided fusion prostate biopsy for the detection of prostate cancer. Urol Oncol. 2020 Sep;38(9):734.e19-734.e25. doi: 10.1016/j.urolonc.2020.03
.020. Epub 2020 Apr 19. PubMed PMID: 32321689.

Kovac E, Carlsson SV, Lilja H, Hugosson J, Kattan MW, Holmberg E, Stephenson AJ. Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. JAMA Netw Open. 2020 Jan 3;3(1):e1919284. doi: 10.1001/jamanetwork
open.2019.19284. PubMed PMID: 31940039; PubMed Central PMCID: PMC6991265.

Bernstein A, Barry E, Fram EB, Sankin A, Kovac E, Stern JM. Does Glomerular Filtration Rate at Discharge After Partial Nephrectomy Predict Long-Term Glomerular Filtration Rate Stability?. J Endourol. 2019 Jun;33(6):488-491. doi: 10.1089/end.2018.0869.
Epub 2019 May 10. PubMed PMID: 30929467.

Suresh T, Sharma J, Goel S, Kovac E, Gao Q, Gartrell B. Patient Characteristics at Prostate Cancer Diagnosis in Different Races at an Academic Center Serving a Diverse Population. Clin Genitourin Cancer. 2019 Apr;17(2):139-144. doi: 10.1016/j.clgc.2018.12.00
3. Epub 2018 Dec 13. PubMed PMID: 30655076.

Bernstein AP, Fram EB, Sankin A, Kovac E, Srivastava A, DiVito J, Stern JM. A comparison of perinephric fat surface area and Mayo Adhesive Probability score in predicting malignancy in T1 renal masses. Urol Oncol. 2018 Nov;36(11):499.e17-499.e22. doi: 10.1016/j.urolonc.2018.07
.018. Epub 2018 Aug 27. PubMed PMID: 30166240.

Zargar H, Shah JB, van Rhijn BW, Daneshmand S, Bivalacqua TJ, Spiess PE, Black PC, Kassouf W. Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-4aN0M0 Bladder Cancer Treated with Radical Cystectomy. J Urol. 2018 Jun;199(6):1452-1458. doi: 10.1016/j.juro.2017.12.
062. Epub 2018 Jan 9. PubMed PMID: 29329894.

Bernstein A, Sarungbam J, Chernyak V, Rajdev L, Kovac E. Renal vein tumor thrombus from metastatic anal gland adenocarcinoma. Urol Case Rep. 2018 Jan;16:51-53. doi: 10.1016/j.eucr.2017.10.
012. eCollection 2018 Jan. PubMed PMID: 29147643; PubMed Central PMCID: PMC5675990.

Dai C, Chung YM, Kovac E, Zhu Z, Li J, Magi-Galluzzi C, Stephenson AJ, Klein EA, Sharifi N. Direct Metabolic Interrogation of Dihydrotestosterone Biosynthesis from Adrenal Precursors in Primary Prostatectomy Tissues. Clin Cancer Res. 2017 Oct 15;23(20):6351-6362. doi: 10.1158/1078-0432.CCR-17-1313. Epub 2017 Jul 21. PubMed PMID: 28733443; PubMed Central PMCID: PMC5641243.

Kovac E, ElShafei A, Tay KJ, Mendez M, Polascik TJ, Jones JS. Five-Year Biochemical Progression-Free Survival Following Salvage Whole-Gland Prostate Cryoablation: Defining Success with Nadir Prostate-Specific Antigen. J Endourol. 2016 Jun;30(6):624-31. doi: 10.1089/end.2015.0719.
Epub 2016 Apr 5. PubMed PMID: 26915721.

Zargar-Shoshtari K, Zargar H, Dinney CP, Ercole CE, Sharma P, Kovac E, Grivas PD, Stephenson AJ, Shah JB, Black PC, Spiess PE. Clinical and therapeutic factors associated with adverse pathological outcomes in clinically node-negative patients treated with neoadjuvant cisplatin-based chemotherapy and radical cystectomy. World J Urol. 2016 May;34(5):695-701. doi: 10.1007/s00345-015-1667-4. Epub 2015 Aug 19. PubMed PMID: 26286880.

Elshafei A, Kovac E, Dhar N, Levy D, Polascik T, Mouraviev V, Yu C, Jones JS. A pretreatment nomogram for prediction of biochemical failure after primary cryoablation of the prostate. Prostate. 2015 Sep;75(13):1447-53. doi: 10.1002/pros.23030. Epub 2015 Jul 14. PubMed PMID: 26172607.

Kovac E, Stephenson AJ. Management of Stage I Nonseminomatous Germ Cell Tumors. Urol Clin North Am. 2015 Aug;42(3):299-310. doi: 10.1016/j.ucl.2015.04.004.
Review. PubMed PMID: 26216817.

Ploussard G, Haddad R, Kovac E, Richard P, Anidjar M, Bladou F. Robot-assisted laparoscopic partial nephrectomy: Early single Canadian institution experience. Can Urol Assoc J. 2013 Sep-Oct;7(9-10):348-54. doi: 10.5489/cuaj.753. PubMed PMID: 24319515; PubMed Central PMCID: PMC3854474.

Kotb AF, Kovac E, Kassouf W, Chin J, Fradet Y, Izawa J, Estey E, Fairey A, Rendon R, Cagiannos I, Lacombe L, Lattouf JB, Bell D, Drachenberg D, Aprikian AG. Radical cystectomy for clinically muscle invasive bladder cancer: does prior non-invasive disease affect clinical outcomes?. World J Urol. 2012 Dec;30(6):761-7. doi: 10.1007/s00345-012-0832-2. PubMed PMID: 22293934.

Kovac E, Azhar RA, Quirouet A, Delisle J, Anidjar M. Construct validity of the LapSim virtual reality laparoscopic simulator within a urology residency program. Can Urol Assoc J. 2012 Aug;6(4):253-9. doi: 10.5489/cuaj.12047.
PubMed PMID: 23093534; PubMed Central PMCID: PMC3433540.

Feifer A, Al-Ammari A, Kovac E, Delisle J, Carrier S, Anidjar M. Randomized controlled trial of virtual reality and hybrid simulation for robotic surgical training. BJU Int. 2011 Nov;108(10):1652-6; discussion 1657. doi: 10.1111/j.1464-410X.2010.10060.x. Epub 2011 Apr 6. PubMed PMID: 21470359.

Evan Kovac Research

Quick Links

Contact Information